BUSINESS (Details Narrative)	Oct. 31, 2020	Jul. 28, 2016
BioCorRx Pharmaceuticals [Member]
Equity issued ownership		75.80%
BioCorRx Pharmaceuticals, Inc [Member]
Management fee	65.00%
Series B Convertible Preferred Stock
Equity issued ownership		24.20%

Percentage of assumed life insurance contract issued and outstanding to life insurance contract issued and outstanding after effect of reinsurance, as disclosed in supplementary reinsurance information. Includes, but is not limited to, dividend and adjustment to face value.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 12
-Paragraph Column F
-Subsection 17

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 235
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-17(Column F))
-URI https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915

Name:	srt_LifeInsuranceInForcePercentageAssumedToNet
Namespace Prefix:	srt_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant